Quoin Pharmaceuticals Ltd. (ADR) share price logo

Quoin Pharmaceuticals Ltd. (ADR)

NASDAQ: QNRX

$4.28

+0.08

(+1.79%)

as on

Quoin Pharmaceuticals Ltd. (ADR) Stock Performance

as on July 30, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $4.22
    $4.37
    downward going graph

    1.40%

    Downside

    2.10%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.25
    $41.80
    downward going graph

    24.07%

    Downside

    876.64%

    Upside

    downward going graph

Quoin Pharmaceuticals Ltd. (ADR) share price movements today

Previous Close
$4.20
Open
$4.31
Volume
129.8K
Day's Low - High
$4.22 - $4.37
52 Week Low - High
$3.25 - $41.80

Quoin Pharmaceuticals Ltd. (ADR) Historical Returns

1 Month Return
-13.22 %
3 Month Return
-35.19 %
1 Year Return
-45.06 %
3 Year Return
-98.4 %
5 Year Return
0 %

Quoin Pharmaceuticals Ltd. (ADR) Stock Fundamentals & Key Indicators

Check Quoin Pharmaceuticals Ltd. (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.6M

EPS (TTM)

-6.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-17.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-231.18%

Quoin Pharmaceuticals Ltd. (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quoin Pharmaceuticals Ltd. (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Quoin Pharmaceuticals Ltd. (ADR) image
Quoin Pharmaceuticals Ltd. (ADR)
BUY$8.6MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$40.0B541.97%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$121.6B143.27%28.3335.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$69.9B20.98%16.0329.65%0.5499999999999999%

Stock Returns calculator for Quoin Pharmaceuticals Ltd. (ADR) Stock including INR - Dollar returns

The Quoin Pharmaceuticals Ltd. (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Quoin Pharmaceuticals Ltd. (ADR) investment value today

Current value as on today

₹61,513

Returns

-₹38,487

(-38.49%)

Returns from Quoin Pharmaceuticals Ltd. (ADR) Stock

-₹43,979 (-43.98%)

Dollar Impact

₹5,492 (+5.49%)

Analyst Recommendation on Quoin Pharmaceuticals Ltd. (ADR) Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Quoin Pharmaceuticals Ltd. (ADR). Average target price of $21.4

Quoin Pharmaceuticals Ltd. (ADR) Share Price Target

Get share price movements and forecasts by analysts on Quoin Pharmaceuticals Ltd. (ADR).

What analysts predicted

80%UPSIDE

Target Price

$21.4

Current Price

$4.28

Analyzed by

8 Analysts

Target

$21.40

Quoin Pharmaceuticals Ltd. (ADR) target price $21.4, a slight upside of 80% compared to current price of $4.28. According to 8 analysts rating.

Indian Investors' Interest in Quoin Pharmaceuticals Ltd. (ADR) Stock

Search interest for Quoin Pharmaceuticals Ltd. (ADR) Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

Quoin Pharmaceuticals Ltd. (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-2
-2
-2
-2
-2
-3
-3
-4
-4
-5
EBITDA
-2
-2
-1
-2
-2
-3
-3
-3
-4
-4
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-1
-2
-2
-3
-3
-3
-4
-4
Income Tax Expense
2
0
1
-8,953
-1
-
-
-
-
-
Net Income
-2
-2
-1
-2
-2
-3
-3
-3
-4
-4
Net Profit Margin
-1324.43%
0.00%
0.00%
0.00%
-2302.75%
0.00%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Ltd. (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
15
15
-1
-1
-6
-9
-9
-9
-16
EBITDA
15
15
-1
-1
-20
-8
-8
-8
-15
Interest Expense
-
-
0
1
1
0
-
-
-
Depreciation
-
-
0
0
0
0
0
0
0
Income Before Tax
15
15
-1
-2
-21
-9
-8
-8
-15
Income Tax Expense
0
0
1
0
-12
0
0
-8,953
-
Net Income
15
15
-1
-2
-21
-9
-8
-8
-15
Net Profit Margin
-5470.36%
-5470.36%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Ltd. (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-1
-2
-2
-3
-3
-3
-15,793
-4
Operating Cash Flow
-1
-2
-2
-2
-2
-3
-2
-5
-4
Investing Cash Flow
-4
3
2
-3
2
1
2
-11
4
Financing Cash Flow
5
0
0
5
0
0
0
18
0
Change in Cash
0
1
0
0
0
-2
0
1
0

Quoin Pharmaceuticals Ltd. (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-5
-4
-2
-21
-9
-8
-9
-15
Operating Cash Flow
-4
-6
-5
-1
-5
-8
-7
-7
-13
Investing Cash Flow
2
3
0
0
0
-10
2
-1
-4
Financing Cash Flow
4
3
6
1
13
14
5
10
18
Change in Cash
2
0
0
-4
7
-4
0
1
0

Global Institutional Holdings in Quoin Pharmaceuticals Ltd. (ADR)

Funds
Holdings
Dauntless Investment Group, LLC
13.12%
Millennium Management LLC
5.09%
GAMMA Investing LLC
0.03%
Resolute Capital Asset Partners LLC
0%
SBI Securities Co Ltd
0%
See all

Quoin Pharmaceuticals Ltd. (ADR) News & Key Events

  • img

    Today's Timeline - 21 October

    Tue, 06:07 PM

    -

    Quoin Pharmaceuticals announces FDA grants Orphan Drug Designation for QRX003 to treat Netherton Syndrome.

Insights on Quoin Pharmaceuticals Ltd. (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 396.7% return, outperforming this stock by 441.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.1% return, outperforming this stock by 713.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, QNRX stock has moved down by -98.4%

About Quoin Pharmaceuticals Ltd. (ADR)

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
OrganisationQuoin Pharmaceuticals Ltd. (ADR)
Headquarters42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
IndustryBiotechnology
CEODr. Michael Myers Ph.D.
E-voting on sharesClick here to vote

Key Management of Quoin Pharmaceuticals Ltd. (ADR)

Name

Title

Ms. Sally Lawlor

Chief Financial Officer

Dr. Michael Myers Ph.D.

Co-Founder, CEO & Chairman

Ms. Denise Carter

Co-Founder, COO & Director

FAQs

What is Quoin Pharmaceuticals Ltd. (ADR) share price today?

Quoin Pharmaceuticals Ltd. (ADR) share price today is $4.28 as on at the close of the market. Quoin Pharmaceuticals Ltd. (ADR) share today touched a day high of $4.37 and a low of $4.22.

What is the 52 week high and 52 week low for Quoin Pharmaceuticals Ltd. (ADR) share?

Quoin Pharmaceuticals Ltd. (ADR) share touched a 52 week high of $41.80 on and a 52 week low of $3.25 on . Quoin Pharmaceuticals Ltd. (ADR) stock price today i.e. is closed at $4.28,which is 89.76% down from its 52 week high and 31.69% up from its 52 week low.

What is Quoin Pharmaceuticals Ltd. (ADR)'s market capitalisation today?

Quoin Pharmaceuticals Ltd. (ADR) market capitalisation is $0.00T as on .

How to invest in Quoin Pharmaceuticals Ltd. (ADR) Stock (QNRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quoin Pharmaceuticals Ltd. (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quoin Pharmaceuticals Ltd. (ADR) Shares that will get you 0.3505 shares as per Quoin Pharmaceuticals Ltd. (ADR) share price of $4.28 per share as on July 30, 2026 at 1:28 am IST.

What is the minimum amount required to buy Quoin Pharmaceuticals Ltd. (ADR) Stock (QNRX) from India?

Indian investors can start investing in Quoin Pharmaceuticals Ltd. (ADR) (QNRX) shares with as little as ₹95.6475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.47 in Quoin Pharmaceuticals Ltd. (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Quoin Pharmaceuticals Ltd. (ADR) share’s latest price of $4.28 as on July 30, 2026 at 1:28 am IST, you will get 2.3364 shares of Quoin Pharmaceuticals Ltd. (ADR). Learn more about fractional shares .